DH-Robotics
Venture Round in 2025
DH Robotics Technology Co., Ltd., founded in 2016 and based in China, specializes in the research and development of robotic hands and industrial robots. The company focuses on creating electric gripping jaws intended to enhance intelligent manufacturing processes. Its products are designed to be stable, secure, and easily integrated, catering to the needs of advanced manufacturing and lean production. By developing cost-effective solutions, DH Robotics aims to support flexible and intelligent demands within the manufacturing sector.
Cornerstone Robotics
Series C in 2025
Cornerstone Robotics develops medical robotic devices designed for precise surgical robotic systems. Their products feature multi-degree-of-freedom robotic arms, real-time imaging integration, and intuitive surgeon interfaces, enabling healthcare providers to perform advanced minimally invasive surgeries with greater control and consistency.
XellSmart
Series B in 2024
XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.
Mufan Power
Series B in 2024
Mufan Power is a new energy high-tech enterprise specializing in turbomachinery. It develops a new generation of zero-carbon hydrogen power generation technologies and products, with hydrogen gas turbines as its core offering. These turbines are intended for distributed energy and data centers, rail transit, ship power, vehicle power, and energy storage peak shaving, supporting carbon-neutral applications across multiple sectors.
FXiaoKe
Venture Round in 2024
FXiaoKe is a Beijing-based company founded in December 2011 that specializes in developing a cloud-based sales management platform tailored for Chinese enterprises. The platform incorporates features of dynamic customer relationship management (CRM) and integrates seamlessly with enterprise WeChat, facilitating efficient collaboration among businesses, individuals, and systems. FXiaoKe’s software solutions support various management functions, including field operation management, distribution chain management, and customer relationship management, specifically targeting small and medium-sized enterprises. The platform is designed to enhance productivity by enabling users to manage sales through social interaction tools and offers online office automation services that facilitate information sharing between personal computers and smartphones. The company's focus encompasses a customer-centric approach with industry-specific strategies aimed at fostering growth in sectors such as high-tech, modern corporate services, fast-moving consumer goods, agriculture, and large-scale manufacturing.
SinoUnited Health
Series D in 2024
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopedics, and neurology services. Established in 2004, the center offers a wide range of treatments, including services for foot and ankle issues, acupuncture, chronic pain, movement disorders, migraines, tremors, electromyography, balance training, home exercise programs, manual therapy, post-stroke care, post-herpetic neuralgia, osteoarthritis, and carpal tunnel syndrome. Known for its commitment to high-quality patient care, SinoUnited Health integrates thoughtful design with international standards to enhance the patient experience. The center has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, ensuring high levels of customer satisfaction among both local residents and visitors.
Founded in 2018, Engitist specializes in researching, manufacturing, and selling high-precision optical measurement and testing equipment for the semiconductor industry. Based in Suzhou, China, the company offers products such as microscopic film measurement, optical defect detection, and optical linewidth measurement equipment, serving customers globally.
DK Medtech
Series E in 2024
DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.
Yanshengchao
Angel Round in 2024
Room A204-1, Floor 2, Building 2, Yard 9, Yike Road
Life Science Park, Changping District
Beijing
China
Chunyu Yisheng
Venture Round in 2024
Chunyu Yisheng, established in 2011 and headquartered in Beijing, is a mobile application designed to enhance communication between physicians and patients. The app allows doctors to access their patients' medical records and facilitates direct interaction, enabling patients to schedule appointments and communicate with their healthcare providers. Additionally, Chunyu Yisheng offers reservation line treatment services, further supporting users in managing their health. The company focuses on leveraging Internet technology to improve health outcomes and streamline the healthcare experience.
DH-Robotics
Series C in 2024
DH Robotics Technology Co., Ltd., founded in 2016 and based in China, specializes in the research and development of robotic hands and industrial robots. The company focuses on creating electric gripping jaws intended to enhance intelligent manufacturing processes. Its products are designed to be stable, secure, and easily integrated, catering to the needs of advanced manufacturing and lean production. By developing cost-effective solutions, DH Robotics aims to support flexible and intelligent demands within the manufacturing sector.
Leapstack
Series C in 2023
Leapstack is an insurance technology company founded in February 2016 and headquartered in Shanghai, with additional offices in Beijing and Nanjing. The company specializes in big data artificial intelligence solutions tailored for commercial insurance providers and social security management agencies. Leapstack develops a data analysis and management platform that enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, and anti-fraud compliance identification. By addressing inefficiencies within the insurance industry, Leapstack aims to improve operational effectiveness and facilitate better decision-making for its clients.
Yanshengchao
Angel Round in 2023
Room A204-1, Floor 2, Building 2, Yard 9, Yike Road
Life Science Park, Changping District
Beijing
China
Puanita is a pet medicine brand seeking development with science and technology for pets.
Puanita is headquartered in China.
Cornerstone Robotics
Series B in 2023
Cornerstone Robotics develops medical robotic devices designed for precise surgical robotic systems. Their products feature multi-degree-of-freedom robotic arms, real-time imaging integration, and intuitive surgeon interfaces, enabling healthcare providers to perform advanced minimally invasive surgeries with greater control and consistency.
CuroVax, established in 2011 and headquartered in Changzhou City, China, specializes in vaccine development and production. The company offers a range of vaccines, including a freeze-dried rabies vaccine for human use and an influenza virus split vaccine. CuroVax employs a dual approach of independent development and collaborative research, supported by multiple technology platforms such as large-scale mammalian cell culture and mRNA vaccine development. It provides biotechnology and microbiology services, focusing on improving health and medical industry standards.
DK Medtech
Venture Round in 2023
DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.
Zeen Health
Series A in 2023
Zeen Health is a digital therapeutics company founded in 2019 and headquartered in Shenzhen, China. The company specializes in providing personalized mental health services through a mobile application, utilizing evidence-based medicine and artificial intelligence technology. By focusing on individualized care, Zeen Health aims to enhance mental health outcomes for its users, offering accessible and effective therapeutic solutions.
1 Yong Cloud
Series B in 2023
1 Yong Cloud is a Beijing-based company founded in 2017 that specializes in developing and operating a tumor diagnosis and treatment standardization platform. The platform is designed to assist healthcare professionals in formulating personalized diagnosis and treatment plans for patients with tumor diseases. By collecting and translating medical data, 1 Yong Cloud aims to enhance the quality and standardization of medical practices while rationalizing treatment expenses. Through its comprehensive data and system services, the company supports physicians in making informed decisions to improve patient outcomes.
Puanita
Pre Seed Round in 2023
Puanita is a pet medicine brand seeking development with science and technology for pets.
Puanita is headquartered in China.
moodytiger
Convertible Note in 2023
moodytiger is a technical athletic apparel brand for children from age of 4 to 16. Today, kids from more than 100 countries, from United States to Australia, from Singapore to Hong Kong, have worn moodytiger outfits in their wonderful active adventure!
Born to redefine kids’ athlectic wear from day one, our products are specially tailored for children with perfect combination of high-tech fabrics and fashion-forward designs, and functionally suited for multiple sports, including tennis, skiing, skating, swimming, outdoor, and everyday active living. As one of the fastest growing and most innovative brands in the category, we thrive to be the new industry benchmark setter with what we do.
Ricoton is a medical device company based in Hunan, China, specializing in the development and production of devices for cerebrovascular diseases. Founded in 2011, the company offers a range of products designed for interventional medicine, including microcatheters, guidewires, and various vascular access devices. Notably, Ricoton's equipment features a comprehensive set that includes a micro guide wire, micro catheter, support catheter, thrombectomy stent, balloon guide catheter, and intracranial balloon dilatation catheter. This innovative lineup provides a one-stop thrombectomy solution aimed at enhancing the treatment and prevention of cerebrovascular conditions.
Xinchuangyuan Semiconductor
Series A in 2023
Xinchuangyuan Semiconductor is a manufacturing company of electronic equipment.
Xinchuangyuan Semiconductor was founded in 2021 and was headquartered in Wuhan, China.
SinoUnited Health
Series C in 2023
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopedics, and neurology services. Established in 2004, the center offers a wide range of treatments, including services for foot and ankle issues, acupuncture, chronic pain, movement disorders, migraines, tremors, electromyography, balance training, home exercise programs, manual therapy, post-stroke care, post-herpetic neuralgia, osteoarthritis, and carpal tunnel syndrome. Known for its commitment to high-quality patient care, SinoUnited Health integrates thoughtful design with international standards to enhance the patient experience. The center has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, ensuring high levels of customer satisfaction among both local residents and visitors.
Biotree Technology
Series A in 2023
Biotree Technology is a high-tech enterprise that specializes in the application, consulting, and development of advanced research technologies within the life sciences sector. Focusing on mass spectrometry and metabolomics, the company provides comprehensive solutions for early detection and analysis in China. With a strong core team experienced in metabolomics, Biotree Technology offers services in scientific research, health testing, and industrial testing. The company is recognized for its innovation in metabolomics products and technology, holding several patents in the field. It has established itself as a leader in metabolomics detection and analysis, maintaining steady growth and profitability over the years. Through its biotechnological testing and consulting services, Biotree Technology assists clients in testing product quality and conducting various biotechnological research projects.
Sunny Dental
Series A in 2022
Sunny Dental, founded in 2007 and based in Beijing, China, specializes in a comprehensive range of orthodontic services. The company provides diagnosis and treatment for dental implants, children’s dentistry, dental restorations, periodontal disease, dental pulp issues, and oral and maxillofacial surgery. Sunny Dental is dedicated to offering professional care and advanced solutions in various aspects of dental health, ensuring a focus on both preventative and restorative treatments.
PureVision
Series A in 2022
PureVision focuses on developing medical devices for ophthalmology.
PureVision was founded in 2022 and was headquartered in Wenzhou, Zhejiang China.
PlusLife Biotech
Series A in 2022
PlusLife Biotech, founded in 2017 and based in Guangzhou, China, focuses on creating innovative molecular diagnostic tools and gene treatment programs utilizing advanced gene technology. The company has developed a range of molecular point-of-care testing (POCT) detection cards and reagents designed for diverse applications, including human respiratory and reproductive tract infections, genotype detection, and pet disease detection. PlusLife Biotech aims to provide customers with cost-effective and user-friendly testing solutions, enhancing the accessibility and efficiency of medical diagnostics.
XellSmart
Series A in 2022
XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.
Weiqiang Medical
Venture Round in 2022
Founded in May 2016 in Hangzhou, Weiqiang Medical is an innovative company focused on peripheral vascular interventional medical devices.
Focallure
Series B in 2022
Focallure is a cosmetic company headquartered in Guangzhou, China, specializing in the development and manufacturing of makeup products. The company emphasizes base makeup and a variety of cosmetics, utilizing big data analysis to enhance its operations. By analyzing consumer product preferences and social content trends, Focallure aims to provide users with an innovative and refreshing makeup experience.
Prismlab China
Series C in 2022
Prismlab China Ltd. is a high-tech enterprise established in 2005, specializing in the development, production, and sales of high-speed light-curing 3D printers. The company integrates optical, mechanical, and electrical technology with computer software and hardware, alongside photopolymer materials. Prismlab's primary focus is on research and development, manufacturing, and marketing of rapid prototyping machines utilizing stereolithography (SLA) technology. Its innovative products are recognized for their quality and performance, reaching customers in over 50 countries and regions, and have garnered critical acclaim from users around the globe.
Fushoukang
Series C in 2022
Shanghai Fushoukang Rehabilitative Home Nursing Services specializes in in-home rehabilitation and nursing care for the elderly, as well as individuals who are weak, sick, or disabled. Founded in 2011 and headquartered in Shanghai, the company offers a range of services including home care, community care, nursing care, and bathing assistance. By focusing on the needs of vulnerable populations, Fushoukang aims to enhance the quality of life for its clients through personalized care in the comfort of their own homes.
OriginCell
Series B in 2022
Shanghai Origincell Biological Cryo Equipment Co., Ltd. is a biomedical enterprise established in 2014, headquartered in Shanghai, China. The company specializes in immunological cell collection, separation, and storage services. It manufactures biobanking storage devices, including cryogenic freezers and biobank systems. In addition to its storage solutions, Origincell develops tumor immunotherapy solutions, utilizing advanced technologies such as the 10-phage display library and humanized antibody technology. These innovations support medical facilities in their cancer treatment efforts, positioning Origincell as a key player in the intersection of biobanking and cancer therapy.
Biotree Technology
Series A in 2022
Biotree Technology is a high-tech enterprise that specializes in the application, consulting, and development of advanced research technologies within the life sciences sector. Focusing on mass spectrometry and metabolomics, the company provides comprehensive solutions for early detection and analysis in China. With a strong core team experienced in metabolomics, Biotree Technology offers services in scientific research, health testing, and industrial testing. The company is recognized for its innovation in metabolomics products and technology, holding several patents in the field. It has established itself as a leader in metabolomics detection and analysis, maintaining steady growth and profitability over the years. Through its biotechnological testing and consulting services, Biotree Technology assists clients in testing product quality and conducting various biotechnological research projects.
Ark Biosciences
Series D in 2022
Ark Biosciences Inc. is a biopharmaceutical company based in Shanghai, China, specializing in the discovery and development of therapeutics aimed at addressing unmet medical needs, particularly in the areas of respiratory viral infections and viral hepatitis. Founded in 2013, the company focuses on developing innovative treatments, including AK0701 for chronic obstructive pulmonary disease, AK0529 for respiratory syncytial virus, AK0612 for influenza, and AK0705 and AK0706 for hepatitis B. Ark Biosciences is committed to advancing antiviral drug research and development to serve both global and Chinese markets.
Puanita
Angel Round in 2022
Puanita is a pet medicine brand seeking development with science and technology for pets.
Puanita is headquartered in China.
Yanshengchao
Seed Round in 2022
Room A204-1, Floor 2, Building 2, Yard 9, Yike Road
Life Science Park, Changping District
Beijing
China
MeetFuture
Series B in 2022
MeetFuture China is a technology-driven company specializing in automated transmission systems for the pan-semiconductor industry. Established in 2016, it offers innovative automation solutions aimed at enhancing industrial upgrading and development. The company leverages control theory, computer technology, and information systems to deliver effective industrial detection, control, optimization, dispatch, and management solutions. By implementing these advanced technologies, MeetFuture enables its clients to reduce operational costs and optimize production parameters, thereby improving overall efficiency and productivity in the semiconductor sector.
MediLink Therapeutics
Series B in 2022
MediLink Therapeutics is a China-based developer of antibody-drug conjugates (ADC) focused on cancer therapy. The company advances next-generation ADCs and aims to address unmet medical needs in China, while pursuing global value through multicenter clinical trials and cross-border collaborations. Its R&D center is in Suzhou.
Wowjoy Technology
Series A in 2022
Wowjoy Technology is a company based in Hangzhou, China, specializing in data-driven medical services. It offers an internet-based medical information platform designed to support large hospital groups and their patients. The company's solutions include various workstations, such as medical integrated workstations, imaging workstations, hospital laboratory workstations, and pharmacy service workstations. These services facilitate efficient information processing for diagnosis, treatment, and billing, ultimately enhancing the effectiveness of healthcare delivery.
Xiaoniao Kuaiyan
Series A in 2022
Xiaoniao Kuaiyan is a Beijing-based company that specializes in home physical examination services. It offers a range of health-related services, including regular check-ups, tumor screening, infection tests, chronic disease surveillance, and customized health assessments. In addition to its core services, the company facilitates business cooperation between enterprises and provides customer service and professional training. Xiaoniao Kuaiyan also focuses on quality management by formulating procedures for quality inspection and developing a comprehensive product knowledge base.
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.
Clinflash Heathcare Technology
Venture Round in 2021
Clinflash is a leading provider of cloud-based solution and relevant professional service in filed of clinical development in China. Clinflash aims to help pharmaceutical companies improve R&D effectiveness and efficiency through providing first class IT solution and professional service.
Sinogen Biopharma
Venture Round in 2021
Sinogen Biopharma is founded with a vision to bridge China's biotech innovation to the US pharma market. The company licenses and develops innovative drugs from China.
Xinchuangyuan Semiconductor
Series A in 2021
Xinchuangyuan Semiconductor is a manufacturing company of electronic equipment.
Xinchuangyuan Semiconductor was founded in 2021 and was headquartered in Wuhan, China.
Yunji Technology
Venture Round in 2021
Yunji Technology is a Chinese robotics company specializing in the development and manufacture of service robots. These robots are designed to deliver goods commercially, improving efficiency and reducing costs for clients in industries such as hospitality, luxury retail, and restaurants.
Cornerstone Robotics
Series B in 2021
Cornerstone Robotics develops medical robotic devices designed for precise surgical robotic systems. Their products feature multi-degree-of-freedom robotic arms, real-time imaging integration, and intuitive surgeon interfaces, enabling healthcare providers to perform advanced minimally invasive surgeries with greater control and consistency.
GenLight Medical
Series B in 2021
GenLight Medical is a company based in Hangzhou, China, that specializes in developing innovative treatment solutions for epilepsy and other neurological disorders. The firm focuses on creating advanced laser medical equipment and technologies aimed at improving patient outcomes in the fields of brain science and neurosurgery. Among its notable advancements are brain-computer control technology, full-cranial implantation techniques for deep brain nerve stimulation, brain computer chips, and systems for magnetic resonance guided laser ablation, which facilitate minimally invasive surgical procedures. GenLight Medical is committed to providing high-end, technologically advanced solutions for patients requiring brain surgery.
Zeen Health
Venture Round in 2021
Zeen Health is a digital therapeutics company founded in 2019 and headquartered in Shenzhen, China. The company specializes in providing personalized mental health services through a mobile application, utilizing evidence-based medicine and artificial intelligence technology. By focusing on individualized care, Zeen Health aims to enhance mental health outcomes for its users, offering accessible and effective therapeutic solutions.
Genevide
Angel Round in 2021
Genevide is a biotech company established in 2019 and based in Suzhou, Jiangsu, China. The company focuses on gene research and development, specifically addressing challenges in nucleic acid detection. Genevide has developed a molecular enzyme cycle screening platform that includes enzyme-mediated one-step sample processing technology and enzyme-mediated double exponential amplification nucleic acid detection technology. These innovations aim to enhance the accessibility and efficiency of nucleic acid detection for researchers.
XellSmart
Seed Round in 2021
XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.
Wowjoy Technology
Series A in 2021
Wowjoy Technology is a company based in Hangzhou, China, specializing in data-driven medical services. It offers an internet-based medical information platform designed to support large hospital groups and their patients. The company's solutions include various workstations, such as medical integrated workstations, imaging workstations, hospital laboratory workstations, and pharmacy service workstations. These services facilitate efficient information processing for diagnosis, treatment, and billing, ultimately enhancing the effectiveness of healthcare delivery.
moodytiger
Series B in 2021
moodytiger is a technical athletic apparel brand for children from age of 4 to 16. Today, kids from more than 100 countries, from United States to Australia, from Singapore to Hong Kong, have worn moodytiger outfits in their wonderful active adventure!
Born to redefine kids’ athlectic wear from day one, our products are specially tailored for children with perfect combination of high-tech fabrics and fashion-forward designs, and functionally suited for multiple sports, including tennis, skiing, skating, swimming, outdoor, and everyday active living. As one of the fastest growing and most innovative brands in the category, we thrive to be the new industry benchmark setter with what we do.
PlusLife Biotech
Series A in 2021
PlusLife Biotech, founded in 2017 and based in Guangzhou, China, focuses on creating innovative molecular diagnostic tools and gene treatment programs utilizing advanced gene technology. The company has developed a range of molecular point-of-care testing (POCT) detection cards and reagents designed for diverse applications, including human respiratory and reproductive tract infections, genotype detection, and pet disease detection. PlusLife Biotech aims to provide customers with cost-effective and user-friendly testing solutions, enhancing the accessibility and efficiency of medical diagnostics.
Berry Oncology
Series B in 2021
Berry Oncology specializes in developing genetic diagnostic solutions for early detection and mid-to-late stage monitoring of various malignant tumors. Their offerings span from companion diagnostics to response monitoring and prognosis prediction for both targeted and immune therapies, aiming to enhance cancer prevention and tumor diagnosis globally. The company's primary mission is to facilitate early diagnosis and treatment of all tumors, ensuring precise care for patients. Berry Oncology aspires to become a global leader in early screening and diagnosis of tumors, particularly in China's tumor gene testing market.
Neuro3 Therapeutics
Seed Round in 2021
Neuro3 Therapeutics is a Hong Kong based company that advances medicines for CNS diseases.
Liangyihui
Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. is an authoritative anti-cancer academic platform based in Shanghai, China. The company focuses on addressing the information asymmetry prevalent in the oncology field by fostering long-term collaborations with various well-known hospitals and authoritative institutions both domestically and internationally. Liangyihui operates an online platform that provides comprehensive educational materials related to tumor treatment and oncology. This includes medical cases, conference information, online courses, and research reports, all aimed at offering reliable information and resources for oncologists, cancer researchers, and patients. The platform serves as a vital tool for promoting cancer prevention and treatment, thereby enhancing public awareness and understanding of cancer-related issues.
NEIWAI is a mid-to-high-end underwear brand founded in Shanghai in 2012, dedicated to providing comfortable clothing that respects the feelings of women. The company emphasizes a design philosophy that harmonizes comfort, function, and beauty, resulting in a diverse range of products suitable for various daily activities, including home and sports. Over the past five years, NEIWAI has served more than 200,000 female customers, reflecting its commitment to meeting the needs of its clientele. By focusing on the comfort of close-fitting clothing, NEIWAI aims to enhance the everyday experiences of its customers through thoughtfully designed underwear.
Insight Lifetech
Series D in 2021
Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.
Hesai Technology
Series D in 2021
Founded in 2014, Hesai Technology specializes in designing and manufacturing LiDAR (Light Detection and Ranging) solutions. Its products facilitate advanced driver assistance systems, autonomous vehicles, and robotics across various industries worldwide.
Insight Lifetech
Secondary Market in 2021
Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.
Data Transmission Group
Secondary Market in 2021
Data Transmission Group is an Internet technology group focusing on big data services in the press and publishing industry.
Data Transmission Group is committed to the digital transformation and upgrading of big data services in the press and publication industry and the digital transformation and upgrading of the media industry, creating a digital content profit model with content providers as the main commercial value, changing the way users acquire and disseminate knowledge, and leading the Internet + upgrade of China's news and publications Replacement and industrial development direction. At present, the group has nearly 200 employees, most of whom are senior publishing, Internet, and software R&D personnel. They have a complete independent R&D system and have rich research results in mobile Internet technology, storage technology, data mining, and publishing integration.
Render is a Chinese manufacturer of high-tech medical products and solutions. Render is a Shenzhen-based company that was founded in 2010.
MeetFuture
Series A in 2021
MeetFuture China is a technology-driven company specializing in automated transmission systems for the pan-semiconductor industry. Established in 2016, it offers innovative automation solutions aimed at enhancing industrial upgrading and development. The company leverages control theory, computer technology, and information systems to deliver effective industrial detection, control, optimization, dispatch, and management solutions. By implementing these advanced technologies, MeetFuture enables its clients to reduce operational costs and optimize production parameters, thereby improving overall efficiency and productivity in the semiconductor sector.
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.
P&R Measurement Technology
Series C in 2021
P&R Measurement Technology Co., Ltd. is a Chinese company specializing in the research, development, and supply of testing and automation solutions. Established in 2011 and headquartered in the Bai Jiao Science and Technology Industrial Park in Zhuhai, the company serves various sectors, including motors, household appliances, consumer electronics, and energy power. It leverages its expertise in engineering signal processing, acoustic and vibration testing, and structural analysis to provide customized and semi-custom engineering testing equipment, data processing tools, and consulting services. P&R Measurement Technology also maintains a presence through subsidiaries in Guangzhou, Suzhou, Hong Kong, and the United States, along with offices in several Chinese cities, including Qingdao, Hefei, Shunde, and Ningde.
SinoUnited Health
Series C in 2021
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopedics, and neurology services. Established in 2004, the center offers a wide range of treatments, including services for foot and ankle issues, acupuncture, chronic pain, movement disorders, migraines, tremors, electromyography, balance training, home exercise programs, manual therapy, post-stroke care, post-herpetic neuralgia, osteoarthritis, and carpal tunnel syndrome. Known for its commitment to high-quality patient care, SinoUnited Health integrates thoughtful design with international standards to enhance the patient experience. The center has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, ensuring high levels of customer satisfaction among both local residents and visitors.
Xizi Education
Series A in 2021
Xizhi Education (Beijing Xizi Education Technology Co., Ltd.) is a leading enterprise in artificial intelligence empowerment education. The headquarters is located in Zhizhi Street, Zhongguancun, which is known as the “China Silicon Valley”. As one of the key incubators of Tsinghua University, from the aspects of policy, capital and talents, it has been strongly supported by Tsinghua's three innovation and entrepreneurship platforms iCenter, Chuang+ and xlab, and won the honor of Zhongguancun High-tech Enterprise.
ZSHK Laboratories
Series A in 2021
ZSHK Lab is a company located in Wan Chai, Hong Kong Island, Hong Kong.
Sincere Edu
Series A in 2021
Sincere Edu is an online education company based in Beijing, China, founded in 2016. It specializes in providing educational services for finance professionals, with a focus on CPA exam preparation. The company offers courses covering subjects such as accounting, tax laws, economics, financial management, and audit. Sincere Edu aims to create a comprehensive learning platform that supports financial professionals throughout their careers by sharing knowledge and cultivating a robust teacher training system.
ET Healthcare
Series G in 2021
ET Healthcare is a medical diagnostics company focused on automated immunodiagnostics. It develops central laboratory analyzers and near-patient testing solutions, with the Pylon Immunochemistry System designed to bring immunoassay performance closer to point-of-care. The system integrates central laboratory capabilities for immunoassays addressing inflammation, cardiac function, fertility, infectious diseases, and tumors, and includes BNP Immunoassay for heart failure management. The company operates from Palo Alto, California, with offices in Shanghai and manufacturing facilities in Suzhou, China. Its products aim to reduce facility space, plumbing, electricity needs, and staffing requirements while enabling high-sensitivity assays and streamlined blood analysis for a range of clinical settings, including hospitals and clinics.
Unisound is a Chinese mobile internet startup focusing on intelligent voice and speech processing technologies. Founded in June 2012, the company owns speech recognition technologies with independently developed intellectual property. Leveraging cloud computing and mobile internet, it launched middleware and cloud platforms for speech recognition services, providing internet enterprises and users with professional speech recognition services. Its core technology team comprises members from major companies, universities, and research institutes, with over 80% holding doctoral degrees and more than 10 years of R&D experience in voice recognition.
MediLink Therapeutics
Series A in 2021
MediLink Therapeutics is a China-based developer of antibody-drug conjugates (ADC) focused on cancer therapy. The company advances next-generation ADCs and aims to address unmet medical needs in China, while pursuing global value through multicenter clinical trials and cross-border collaborations. Its R&D center is in Suzhou.
Liangyihui
Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. is an authoritative anti-cancer academic platform based in Shanghai, China. The company focuses on addressing the information asymmetry prevalent in the oncology field by fostering long-term collaborations with various well-known hospitals and authoritative institutions both domestically and internationally. Liangyihui operates an online platform that provides comprehensive educational materials related to tumor treatment and oncology. This includes medical cases, conference information, online courses, and research reports, all aimed at offering reliable information and resources for oncologists, cancer researchers, and patients. The platform serves as a vital tool for promoting cancer prevention and treatment, thereby enhancing public awareness and understanding of cancer-related issues.
Miaoshou Doctor
Series E in 2021
Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.
Erwan Technology
Series D in 2021
Erwan Technology is an online education provider based in Dalian Shi, Liaoning, China, specializing in financial investment education for Chinese middle-class families. Founded in 2016, the company has established itself as the largest online investment education platform in terms of user base, reaching over 10 million students across 34 provincial administrative regions. Erwan Technology offers a diverse array of paid educational modules, including live broadcasts, boutique investment courses, and hands-on workshops, designed to impart essential financial skills. The platform covers various financial topics, such as investment strategies, risk management, and wealth management, thereby equipping its viewers with fundamental financial knowledge. Its commitment to popularizing financial education has positioned it among the top three platforms in revenue within the industry.
Erwan Technology
Series E in 2021
Erwan Technology is an online education provider based in Dalian Shi, Liaoning, China, specializing in financial investment education for Chinese middle-class families. Founded in 2016, the company has established itself as the largest online investment education platform in terms of user base, reaching over 10 million students across 34 provincial administrative regions. Erwan Technology offers a diverse array of paid educational modules, including live broadcasts, boutique investment courses, and hands-on workshops, designed to impart essential financial skills. The platform covers various financial topics, such as investment strategies, risk management, and wealth management, thereby equipping its viewers with fundamental financial knowledge. Its commitment to popularizing financial education has positioned it among the top three platforms in revenue within the industry.
Yunji Technology
Series C in 2021
Yunji Technology is a Chinese robotics company specializing in the development and manufacture of service robots. These robots are designed to deliver goods commercially, improving efficiency and reducing costs for clients in industries such as hospitality, luxury retail, and restaurants.
Kira Pharmaceuticals
Series B in 2021
Kira Pharmaceuticals, established in 2017 and headquartered in Suzhou, China, is a biotechnology company focused on developing innovative therapies targeting the complement system to treat immune-mediated diseases.
Cornerstone Robotics
Series A in 2021
Cornerstone Robotics develops medical robotic devices designed for precise surgical robotic systems. Their products feature multi-degree-of-freedom robotic arms, real-time imaging integration, and intuitive surgeon interfaces, enabling healthcare providers to perform advanced minimally invasive surgeries with greater control and consistency.
Insight Lifetech
Series C in 2020
Insight Lifetech is a medical technology company focused on developing and manufacturing innovative solutions for the diagnosis and treatment of cardiovascular diseases. The company has established a comprehensive platform that integrates research and development, manufacturing, and commercialization, facilitating collaboration across its operations. This synergy accelerates product development, enhances cost-efficiency, and fosters innovation. Notably, Insight Lifetech developed the first domestic fractional flow reserve (FFR) system in China, which received approval from the National Medical Products Administration. Through its high-quality medical devices and advanced technologies, the company aims to provide reliable precision in cardiovascular diagnosis and therapy, ultimately enabling physicians to save and improve patients' lives.
MicroTech Medical
Series D in 2020
MicroTech Medical, founded in January 2011 in Hangzhou Future Technical City, is a company focused on the research, development, and manufacturing of innovative and affordable medical devices for diabetes care. The firm specializes in creating both treatment and monitoring devices aimed at improving diabetes management, primarily serving the Chinese market while also reaching international customers. With significant backing from Eli Lilly and Company, MicroTech Medical is dedicated to enhancing the quality of life for individuals living with diabetes through advanced technology solutions.
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.
Kira Pharmaceuticals
Venture Round in 2020
Kira Pharmaceuticals, established in 2017 and headquartered in Suzhou, China, is a biotechnology company focused on developing innovative therapies targeting the complement system to treat immune-mediated diseases.
InventisBio
Series D in 2020
InventisBio Inc. is a biotechnology company focused on discovering and developing innovative therapeutics for cancer and metabolic diseases. Founded in 2013 and based in Pudong, China, the company has developed a range of small molecule drug candidates targeting lung cancer, breast cancer, and gout. Among its notable products is D-0316, a third-generation EGFR-T790M tyrosine kinase inhibitor. InventisBio is also engaged in creating targeted immuno-oncology therapies that can be used in combination with existing treatments, such as PD-1 antibodies, to address various cancer indications. Co-founded by Dr. Yaolin Wang and a team of scientists with extensive experience in drug discovery at major pharmaceutical companies, InventisBio aims to provide effective therapies for significant health challenges.
Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.
Tungee, founded in 2016, specializes in providing intelligent sales solutions for B2B enterprises. By leveraging artificial intelligence and big data, the company has developed a comprehensive sales forecasting platform that encompasses various functions, including lead mining, business opportunity engagement, customer relationship management, and order analysis. Tungee's innovative approach addresses the challenges faced by businesses in identifying, contacting, and managing customers, leading to more efficient acquisition of accurate sales leads and reduced customer acquisition costs. As a leader in the Chinese intelligent sales sector, Tungee has successfully served over 3,000 enterprise clients, including prominent organizations such as Alibaba and China Mobile.
New Horizon Health
Series E in 2020
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.
52toys
Secondary Market in 2020
52toys is an animation and intellectual property operator based in Beijing that develops its own IP and licenses IP for toy products, delivering entertainment to consumers of all ages and enabling exploration of new and familiar designs.
Miaoshou Doctor
Series D in 2020
Miaoshou Doctor is a healthcare service platform established in 2015 by Tao He and Daoliang Han, headquartered in Beijing. The company focuses on facilitating communication between patients and healthcare professionals, enabling effective management of post-diagnosis outcomes. Its platform empowers doctors to actively monitor their patients' health through ongoing counseling and prescription support, enhancing the overall patient care experience. By streamlining interactions and follow-ups, Miaoshou Doctor aims to improve health outcomes and foster better relationships between patients and their healthcare providers.
Shukun Technology is a Chinese healthcare company founded in 2017 and headquartered in Beijing. It specializes in developing diagnostic systems that leverage machine learning and artificial intelligence to detect cardiovascular diseases and tumors. By employing deep learning algorithms, Shukun Technology intelligently analyzes medical images to automatically identify lesions and generate comprehensive reports. The company's innovations aim to enhance the efficiency of medical professionals, ultimately improving the quality of diagnosis and treatment in primary healthcare settings.
OriginCell
Series A in 2020
Shanghai Origincell Biological Cryo Equipment Co., Ltd. is a biomedical enterprise established in 2014, headquartered in Shanghai, China. The company specializes in immunological cell collection, separation, and storage services. It manufactures biobanking storage devices, including cryogenic freezers and biobank systems. In addition to its storage solutions, Origincell develops tumor immunotherapy solutions, utilizing advanced technologies such as the 10-phage display library and humanized antibody technology. These innovations support medical facilities in their cancer treatment efforts, positioning Origincell as a key player in the intersection of biobanking and cancer therapy.
MicroTech Medical
Venture Round in 2020
MicroTech Medical, founded in January 2011 in Hangzhou Future Technical City, is a company focused on the research, development, and manufacturing of innovative and affordable medical devices for diabetes care. The firm specializes in creating both treatment and monitoring devices aimed at improving diabetes management, primarily serving the Chinese market while also reaching international customers. With significant backing from Eli Lilly and Company, MicroTech Medical is dedicated to enhancing the quality of life for individuals living with diabetes through advanced technology solutions.
New Horizon Health
Series D in 2020
New Horizon Health is a biotechnology company based in Hangzhou, China, with an additional office in Beijing, specializing in the development of innovative technologies for early cancer detection and screening. Founded in 2015, the company primarily focuses on gastrointestinal cancers, offering products such as the ColoClear and Pupu Tube, which utilize fecal gene analysis (FIT-DNA) technology for colorectal cancer screening. These products enable users to conduct in-home tests, allowing for the early detection of colon cancer and precancerous lesions that may not be identified through traditional blood tests. New Horizon Health aims to reduce cancer morbidity and mortality rates by promoting accessible and efficient health services, leveraging big data and artificial intelligence in its screening technologies. The company's commitment to early cancer screening reflects its mission to enhance public health by facilitating widespread access to vital diagnostic tools.
Chuhang Tech
Series A in 2020
Nanjing Chuhang Technology Co., Ltd. specializes in the development and production of millimeter-wave radar technology and advanced driver-assistance systems (ADAS). Founded in 2018 and headquartered in Nanjing, China, the company produces 77 GHz angle radars and forward midrange radars that enable various applications such as blind zone detection, automatic parking, emergency braking, adaptive cruise control, and forward crossing warning. Additionally, its technology supports gesture recognition, heartbeat breath detection, dangerous liquid level detection, smart security, and agricultural drone operations. Chuhang Tech operates subsidiaries in several Chinese cities as well as in Stuttgart, Germany, emphasizing its commitment to enhancing vehicle safety and promoting efficient agricultural practices through innovative radar solutions.
Berry Oncology
Series A in 2020
Berry Oncology specializes in developing genetic diagnostic solutions for early detection and mid-to-late stage monitoring of various malignant tumors. Their offerings span from companion diagnostics to response monitoring and prognosis prediction for both targeted and immune therapies, aiming to enhance cancer prevention and tumor diagnosis globally. The company's primary mission is to facilitate early diagnosis and treatment of all tumors, ensuring precise care for patients. Berry Oncology aspires to become a global leader in early screening and diagnosis of tumors, particularly in China's tumor gene testing market.
Kira Pharmaceuticals
Series B in 2020
Kira Pharmaceuticals, established in 2017 and headquartered in Suzhou, China, is a biotechnology company focused on developing innovative therapies targeting the complement system to treat immune-mediated diseases.
DiShangTie Car Rental (Shenzhen) Co., Ltd. is a company based in Shenzhen, China, specializing in the rental and maintenance of commercial electric vehicles (EVs) for passenger and cargo transportation. Established in 2015, the company focuses on the transportation and logistics sector, providing sustainable energy vehicle rental services tailored for the new energy logistics market. DiShangTie also manufactures electric car charging stations, supporting its commitment to offering green and sustainable vehicle leasing alternatives to major express logistics and urban distribution companies. Through its services, the company aims to facilitate the adoption of environmentally friendly transport solutions in China.
Chushou
Debt Financing in 2020
Chushou is a Chinese social networking platform that specializes in live video streaming, primarily focused on mobile gaming. The platform hosts approximately 2.7 million live streaming broadcasters, with around 150,000 active hosts engaging daily. Chushou allows gamers to interact with one another while live streaming their mobile gaming activities, creating a dynamic environment for both broadcasters and viewers. Through its mobile-based services, Chushou facilitates a unique community for gamers, fostering interaction and engagement within the gaming ecosystem.